- Home
- AUPH vs GCT Comparison
AUPH vs GCT Comparison
Compare AUPH & GCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- GCT
- Stock Information
- Founded
- AUPH 1993
- GCT 2019
- Country
- AUPH Canada
- GCT United States
- Employees
- AUPH N/A
- GCT N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- GCT Catalog/Specialty Distribution
- Sector
- AUPH Health Care
- GCT Consumer Discretionary
- Exchange
- AUPH Nasdaq
- GCT Nasdaq
- Market Cap
- AUPH 1.4B
- GCT 798.3M
- IPO Year
- AUPH 1999
- GCT 2022
- Fundamental
- Price
- AUPH $12.30
- GCT $29.71
- Analyst Decision
- AUPH Strong Buy
- GCT Buy
- Analyst Count
- AUPH 3
- GCT 2
- Target Price
- AUPH $12.00
- GCT $24.00
- AVG Volume (30 Days)
- AUPH 1.5M
- GCT 1.2M
- Earning Date
- AUPH 11-06-2025
- GCT 11-06-2025
- Dividend Yield
- AUPH N/A
- GCT N/A
- EPS Growth
- AUPH N/A
- GCT 19.25
- EPS
- AUPH 0.42
- GCT 3.31
- Revenue
- AUPH $260,111,000.00
- GCT $1,193,610,000.00
- Revenue This Year
- AUPH $16.92
- GCT $4.65
- Revenue Next Year
- AUPH $14.43
- GCT $4.94
- P/E Ratio
- AUPH $29.12
- GCT $8.95
- Revenue Growth
- AUPH 25.59
- GCT 21.20
- 52 Week Low
- AUPH $6.55
- GCT $11.17
- 52 Week High
- AUPH $12.90
- GCT $34.50
- Technical
- Relative Strength Index (RSI)
- AUPH 56.77
- GCT 56.90
- Support Level
- AUPH $12.06
- GCT $25.15
- Resistance Level
- AUPH $12.90
- GCT $31.45
- Average True Range (ATR)
- AUPH 0.39
- GCT 1.38
- MACD
- AUPH -0.08
- GCT 0.14
- Stochastic Oscillator
- AUPH 54.89
- GCT 72.38
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About GCT GigaCloud Technology Inc
GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.